Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.

The oncology therapy developer has gone public in an upsized offering that provided exits for SoftBank Vision Fund and Alphabet's GV unit.

UPMC's patient telemedicine service Curavi Health has completed a merger that enables its founding institution to retain an equity stake.

Ascension Ventures helped add $6m to a round for the telemedicine technology provider already featuring Cigna and MemorialCare Health.

Section 32 has led a $46.7m series B round that will support further development of the MIT spinout's biosensor-based diagnostics device.

Intermountain Ventures, already among the medical chatbot developer's customers, participated in a $13.6m round that took its total funding past $20m.

Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.

The ophthalmologic drug developer has gone public three years after being founded by WuXi AppTec-backed 6 Dimensions Capital.

Pfizer Ventures, billed as an existing investor, contributed to the $72.5m close of the antibody-drug conjugate developer's latest round.

The ultrasound system developer's Edwards Lifesciences-backed series B round will fund product development and commercial growth.